Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital
Recruiting · NCT07299500 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital, Strasbourg, France
View the official record on ClinicalTrials.gov →What this trial is about
Toxoplasmosis in HIV-positive individuals is well-studied and has a codified management protocol, which is not the case for other immunodeficiencies, except for recent recommendations in the context of hematopoietic stem cell transplantation. A description of this population is necessary to estimate the number of patients affected and to define their specific management (diagnosis, treatment, prevention).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adult (≥18 years)
- Immunocompromised (i.e., solid organ transplant recipient, hematological malignancy, cancer patient, patient treated with immunosuppressive therapy or therapy affecting the immune system by any mechanism, hematopoietic stem cell transplant recipient, patient with an autoimmune disease or immunodeficiency, whether primary or secondary).
- At least one positive toxoplasmosis PCR test (regardless of tissue)
Exclusion criteria
- Subject who has expressed opposition to the reuse of their data for scientific research.
- HIV positive
- Congenital toxoplasmosis
- Isolated ocular toxoplasmosis in immunocompetent individuals
Where it is running
1 location listed.
- Service d'immunologie clinique - Hôpitaux Universitaires de Strasbourg - Strasbourg, France